Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Pathological pain and the neuroimmune interface|
|Citation:||Nature Reviews Immunology, 2014; 14(4):217-231|
|Publisher:||Nature Publishing Group|
|Organisation:||Institute for Photonics & Advanced Sensing (IPAS)|
|Peter M. Grace, Mark R. Hutchinson, Steven F. Maier & Linda R. Watkins|
|Abstract:||Reciprocal signalling between immunocompetent cells in the central nervous system (CNS) has emerged as a key phenomenon underpinning pathological and chronic pain mechanisms. Neuronal excitability can be powerfully enhanced both by classical neurotransmitters derived from neurons, and by immune mediators released from CNS-resident microglia and astrocytes, and from infiltrating cells such as T cells. In this Review, we discuss the current understanding of the contribution of central immune mechanisms to pathological pain, and how the heterogeneous immune functions of different cells in the CNS could be harnessed to develop new therapeutics for pain control. Given the prevalence of chronic pain and the incomplete efficacy of current drugs — which focus on suppressing aberrant neuronal activity — new strategies to manipulate neuroimmune pain transmission hold considerable promise.|
|Keywords:||Central Nervous System; Animals; Humans; Pain; Inflammation; Chemokines; Signal Transduction; Neuroimmunomodulation; Models, Biological; Toll-Like Receptors; Pain Management|
|Rights:||© 2014 Macmillan Publishers Limited. All rights reserved.|
|Appears in Collections:||IPAS publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.